Equinix — Feb 11, 2026 release
Fiscal 2025 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001101239-26-000030
Showing in the filing
Adjusted EBITDA
“$1.283 and $1.323 billion”
Period
Q1 FY2026
Measure
Company-defined measure
Source
Prose
All guidance in this release · 24
Quarterly cash dividend
“$5.16 per share”
Revenues for FY2026
“$10,123 - 10,223”
Adjusted EBITDA Margin % for Q1 FY2026
“51 - 52%”
Recurring Capital Expenditures % of Revenues for FY2026
“~3%”
Recurring Capital Expenditures % of Revenues for Q1 FY2026
“1 - 2%”
AFFO per Share (Diluted) for FY2026
“$41.93 - 42.74”
Expected Cash Dividends for FY2026
“~$2,036”
Revenues for Q1 FY2026
“$2.496 and $2.536 billion”
Adjusted EBITDA for Q1 FY2026
“$1.283 and $1.323 billion”
Recurring capital expenditures for Q1 FY2026
“$28 and $48 million”
Total revenues for FY2026
“$10.123 and $10.223 billion”
Total revenues growth (as-reported) for FY2026
“approximately 10 - 11%”
Total revenues growth (normalized and consta… for FY2026
“9 - 10%”
Adjusted EBITDA for FY2026
“$5.141 and $5.221 billion”
Adjusted EBITDA margin for FY2026
“51%”
Adjusted EBITDA margin expansion for FY2026
“approximate 200 basis-point expansion”
AFFO for FY2026
“$4.158 and $4.238 billion”
AFFO growth (as-reported) for FY2026
“11 - 13%”
AFFO growth (normalized and constant currency) for FY2026
“9 - 11%”
AFFO per share growth (as-reported) for FY2026
“9 - 12%”
AFFO per share growth (normalized and consta… for FY2026
“8 - 10%”
Total capital expenditures for FY2026
“$3.655 and $4.155 billion”
Non-recurring capital expenditures (excludes… for FY2026
“$3.385 and $3.865 billion”
Recurring capital expenditures for FY2026
“$270 and $290 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
For the first quarter of 2026, the company expects revenues to range between $2.496 and $2.536 billion, an increase of 4% at the midpoint over the previous quarter, on both an as-reported and a normalized and constant currency basis. This guidance includes a $20 million foreign currency benefit when compared to the average FX rates in Q4 2025. Adjusted EBITDA is expected to range between $1.283 and $1.323 billion. This guidance includes an $11 million foreign currency benefit when compared to the average FX rates in Q4 2025. Recurring capital expenditures are expected to range between $28 and $48 million. For the full year of 2026, total revenues are expected to range between $10.123 and $10.223 billion, an as-reported increase of approximately 10 - 11% over the previous year, or 9 - 10% on a normalized and constant currency basis. This guidance includes a $36 million foreign currency benefit when compared to the prior guidance rates. Adjusted EBITDA is expected to range between $5.141 and $5.221 billion, reflecting an adjusted EBITDA margin of 51%, an approximate 200 basis-point expansion over the previous year. This guidance also includes a $17 million foreign currency benefit when compared to prior guidance. AFFO is expected to range between $4.158 and $4.238 billion, an increase of 11 - 13% over the previous year on an as-reported basis, or 9 - 11% on a normalized and constant currency basis. This guidance also includes a $13 million foreign currency benefit when compared to prior guidance rates. AFFO per share is expected to range between $41.93 and $42.74, a 9 - 12% as-reported incre
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.